Search for: "Watson Pharmaceuticals, Inc."
Results 1 - 20 of 38
Sorted by Relevance | Sort by Date
16 Oct, 2006 7:58 pm
... case against Andrx. Source: Impax press release. Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. AndroGel, a treatment for testosterone deficiency, had sales of $225 million in
2002. Watson, the first ANDA filer, will be allowed to begin marketing its generic product no later than August 31, 2015, which is five years
...
4 Dec, 2007 9:28 pm
By Sherri Oslick -- Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, and Watson Pharmaceuticals,
Inc., have announced that they have reached a settlement agreement in Biovail's lawsuit against Andrx Pharmaceuticals, Inc., a subsidiary of Watson. The lawsuit was filed following a paragraph IV certification as part of Andrx's...
2 Oct, 2008 1:12 pm
... excerpted from an October 1, 2008 press release that appeared at the Sun Herald: Watson Pharmaceuticals, Inc. (NYSE: WPI), a
leading specialty pharmaceutical company, today confirmed the receipt of a Paragraph IV Certification Notice Letter relating ... are invalid, unenforceable and/or will not be
infringed by their manufacture, use or sale of the product described in its ANDA. Watson currently is reviewing the Notice Letter and, by
statute, has 45 days to initiate a patent infringement lawsuit ...
20 Mar, 2008 1:55 am
... the patent owners to the punch and filed a declaratory judgment action because it believes that it will be sued for patent infringement. Watson seeks a declaration from the Court that the patent is "is invalid, unenforceable and/or not infringed by the commercial manufacture, use or sale of the
drub product described in Watson's ANDA." The case is titled Watson Laboratories, Inc., v.
Duramed Pharmaceuticals, Inc., SACV08-0243 JVS (C.D. California).
6 Mar 7:03 am
... Trade Comm'n et al. v. Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). In a
press release announcing the action, the FTC ... U.S. sales in 2007. The complaint also names generic pharmaceutical companies Watson
Pharmaceuticals, Par Pharmaceuticals and Paddock Laboratories. Pursuant to the regulatory framework of the Drug ... generic company entered the market before that date.
The FTC alleges that Solvay and Watson simultaneously entered into a co-promotion deal in which Solvay agreed to share ...
5 Mar, 2008 8:20 pm
... . (NYSE: BRL) today announced that its wholly-owned subsidiary, Duramed Pharmaceuticals, Inc., has filed suit against Watson
Pharmaceuticals (NYSE: WPI) and its subsidiary, Watson Laboratories, Inc., for infringement of the patent protecting Duramed's
SEASONIQUE(R) extended-cycle oral contraceptive product. The Company's SEASONIQUE Patent No. 7,320,969 is due to expire on January 30, 2024. ...
9 Oct 9:11 am
... v. Gates Corporation (trademark infringement) 9/16: Fair Isaac Corporation v. Actimize Inc. and NICE Systems Ltd. (patent infringement) 9/17: US Philips Corporation v.
Samsung Electronics Company Ltd. and Samsung Electronics America Inc. (patent infringement) 9/18: Research Foundation of State University of New York, New ... Inc. (patent
infringement) 9/25: Cephalon Inc. v. Watson Pharmaceuticals Inc., Watson
Laboratories, Inc. and Watson Pharma Inc. (patent infringement) 10/5: Fairchild ...
9 Aug 10:02 pm
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that one lot of 100
mcg/hr Fentanyl Transdermal System patches sold in the United States ... Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. The affected lot of Fentanyl
Transdermal System patches was shipped to customers between April 2, 2009 and May 20, 2009. No other strengths or lots were affected ...
18 Oct 5:42 pm
... district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson
Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay's branded testosterone-replacement drug AndroGel, a
prescription pharmaceutical with annual sales of more than $400 million. "At a time [...]... Senate Bill Would Prevent Reverse Pharma PaymentsThe Patent Docs are reporting that
on ...
9 Apr 9:14 pm
... Pillai -- Delaware District Court Invalidates Concerta® Patent The U.S. District Court for the District of Delaware has ruled that Watson
Pharmaceuticals, Inc.'s generic version of Concerta® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and ... at issue, U.S.
Patent No. 6,919,373. Before the trial commenced, the plaintiffs had offered Watson a covenant not to sue for Watson's practice of another patent at issue in the case, U.S. Patent No. 6,930,129. ...
24 Dec, 2008 9:04 am
... will be able to sell generic versions Clarinex-D12 and Clarinex-D24 with six-months marketing exclusivity, and Clarinex Reditabs with six-months marketing co-exclusivity starting
from 2012. Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc.
7 Apr 5:00 am
... seat back can also detach if not snapped fully into place. The company has received one report of a detached seat back that resulted in a fractured skull. Watson Pharmaceuticals, Inc. recalled one lot of Propafenone HCL 225 milligram tablets, a prescribed drug used to treat cardiac arrhythmia, sold
in 100 count bottles in the United States. Some of the tablets may contain higher levels of the active ingredient than ...
8 Feb, 2008 7:00 pm
... Law360), (Patent Docs), Fosamax (Alendronate) - Merck's Fosamax patent expires: Watson Pharmaceuticals to distribute authorized
generic version, Teva and Barr also launch ... Wegner), Frivolous appeal, briefing and argument: F & G Research, Inc v Dynapoint Taiwan: (Harold Wegner), Northern District of
California 's new ... Knowledge), Retroactive work for hire agreements - transfer of copyright: Gladwell Government Services, Inc v County of Marin: (Patry Copyright Blog),:
Public interest and industry ...
8 Dec, 2007 11:00 am
... attorney's fees despite earlier win against Teva: (IPLaw360), Exelon (Rivastigmine) - Sun Pharmaceutical Industries and Watson
Pharmaceuticals settle with Novartis: (IPLaw360), (Generic Pharmaceuticals & IP), (BIO Smartbrief), Levaquin (Levofloxacin) - Supreme Court ... : (IPLaw360),
(Washington State Patent Law Blog), Microsoft - Anascape Ltd., Microsoft Corp. and Nintendo Inc - Markman claim construction handed down: (IPLaw360), Motion Picture Association
of America (MPAA) - content filtering ...
9 Apr 7:52 am
... Argentine government over 'GM soy-ready RR' (Moeller IP) Australia: Pharmaceutical manufacture for export - what do you think? (IP Think Tank) Brazilian public- ... Antitrust
class action complaint filed against Androgel manufacturers Unimed, Solvay, Watson, Par and Paddock (SmartBrief) (GenericsWeb) Aspirin -
Poland: Polish Patent Office ... Combigan ANDA (Law360) Concerta (Methylphenidate) - US: District Court Delaware rules Watson's generic
Concerta would not infringe Johnson & Johnson patents ...
7 Mar, 2008 2:00 am
... Patent Docs), US: District Court Judge accepts claim interpretation 'proffer' on motion for summary judgment in Unigen Pharmaceuticals Inc v Walgreen Company:
(Washington State Patent Law Blog), US: Stem cells: missing out ... generic version of Janssen Pharmaceutical's Risperdal: (GenericsWeb), (IP Law360), Seasonique
(Levonorgestrel/Ethinyl estradiol) - Watson applies to market generic Seasonique, prior to the expiration of patents owned by Duramed, a
subsidiary of Barr Pharmaceuticals - Barr sues ...
16 Aug, 2008 2:43 am
... ), US: Biotech rivals Eppendorf AG and Bio-Rad Lab's Inc drop patent suits against each other over cell-breeding and ... generic Lipitor: (Law360), (GenericsWeb), Naprelan
(Naproxen) - US: District Court rules that Watson Pharmaceuticals' generic Naprelan infringes Elan's patent: (GenericsWeb), (Law360),
Nicomide - ... TTAB affirms mere descriptiveness refusal of 'ITALIAN SUSHI': In re Alfredo International Inc (non-precedential): (TTABlog), Aloft - Aloft voluntarily dismisses
two additional companies ...
8 Nov, 2007 9:00 pm
... of top intellectual property news breaking in the blogosphere and internet. Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this
week. Interesting news this week (well, the end of last week) was the lawsuit by JK ... 180-Day exclusivity draws letters from 8 generics: (OrangeBookBlog), (Generic
Pharmaceuticals & IP), Yaz - Bayer AG has filed a lawsuit against Watson Laboratories Inc., alleging patent infringement
related to the oral contraceptive Yaz: ...
13 Jun, 2008 3:40 am
... US: Cephalon launches patent infringement suits in Nevada and Delaware against Watson Pharmaceuticals over ANDA to manufacture
generic Fentora: (Patent Docs), Lovenox (Enoxaparin) ... (IPRoo), Costs decision: Nutrasweet Australia Pty Ltd v Ajinomoto Co Inc: (IPRoo), Gordon J upholds breach of
confidentiality and copyright: Krueger Transport ... Storage: (IPRoo), TMO decides SIX IN THE CITY registrable: Home Box Office, Inc v Susan Stigwood Pty Ltd: (IPRoo), Employment
qualifications for registered patent ...
17 Jun 3:02 am
... Alphapharm Pty Ltd (Mallesons Stephen Jaques) Mucinex (Guaifenesin) - US: Reckitt Benckiser files patent infringement suit against Watson
Lab's following ANDA to manufacture generic Mucinex (Patent Docs) Nuvaring (Etonogestrel, Ethinyloestradiol) - Australia: ... - Sandoz sues Johnson & Johnson over contraceptive pill
patent (GenericsWeb) OxyContin (Oxycodone) - US: KV Pharmaceutical Co, Purdue Pharma settle OxyContin patent dispute (SmartBrief) Solodyn (Minocycline) - US: Medicis files patent
...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog
Search | Technorati | Google | MSN | Yahoo!